News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Higgons John Duncan
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/22/2021 |
4
| Higgons John Duncan (Director) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Sold 1,500 shares
@ $12, valued at
$18k
Sold 200 shares
@ $11.11, valued at
$2.2k
|
|
| 07/02/2020 |
4/A
| Higgons John Duncan (Director) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Granted 15,700 options to buy
@ $7.58, valued at
$119k
|
|
| 06/29/2020 |
4
| Higgons John Duncan (Director) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Granted 13,550 options to buy
@ $7.58, valued at
$102.7k
|
|
| 01/08/2020 |
4
| Higgons John Duncan (Director) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Sold 1,500 shares
@ $8.11, valued at
$12.2k
|
|
| 06/13/2019 |
4
| Higgons John Duncan (Director) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Granted 15,700 options to buy
@ $4.46, valued at
$70k
|
|
| 06/21/2018 |
4
| Higgons John Duncan (Director) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Granted 13,550 options to buy
@ $7.92, valued at
$107.3k
|
|
| 02/02/2017 |
4
| Higgons John Duncan (Director) has filed a Form 4 on Jounce Therapeutics, Inc. |
| 01/26/2017 |
3
| Higgons John Duncan (Director) has filed a Form 3 on Jounce Therapeutics, Inc. |
|
|